Recombinant Podospora anserina NADH-ubiquinone oxidoreductase chain 3 (ND3)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Our default shipping includes standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your preparation.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months under the same conditions.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. To request a specific tag, please inform us in advance to enable prioritized development.
Synonyms
ND3; NADH-ubiquinone oxidoreductase chain 3; NADH dehydrogenase subunit 3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-137
Protein Length
full length protein
Species
Podospora anserina (strain S / ATCC MYA-4624 / DSM 980 / FGSC 10383) (Pleurage anserina)
Target Names
ND3
Target Protein Sequence
MSSMTLFILFVSIIALLFLFINLIFAPHNPYQEKYSIFECGFHSFLGQNRTQFGVKFFIF ALVYLLLDLEILLTFPFAVSEYVNNIYGLIILLGFITIITIGFVYELGKSALKIDSRQVI TMTRFNYSSTIEYLGKI
Uniprot No.

Target Background

Function
Recombinant *Podospora anserina* NADH-ubiquinone oxidoreductase chain 3 (ND3) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It's considered essential for the minimal catalytic assembly. Complex I facilitates electron transfer from NADH to the respiratory chain, with ubiquinone believed to be the immediate electron acceptor.
Database Links
Protein Families
Complex I subunit 3 family
Subcellular Location
Mitochondrion membrane; Multi-pass membrane protein.

Q&A

What is Podospora anserina and why is it used as a model organism?

Podospora anserina is a filamentous ascomycete fungus from the order Sordariales that serves as an important model organism in molecular biology research. It is particularly valuable for studying senescence (aging), prions, sexual reproduction, meiotic drive, and mitochondrial physiology. As a non-pathogenic coprophilous fungus, P. anserina naturally colonizes the dung of herbivorous animals including horses, rabbits, cows, and sheep . The organism has an obligate sexual and pseudohomothallic life cycle, and its optimal growth temperature is 25-27°C . P. anserina diverged from Neurospora crassa approximately 75 million years ago based on 18S rRNA analysis, with protein orthologs sharing 60-70% homology . Its ease of cultivation on various media (potato dextrose, cornmeal agar/broth, or synthetic medium) and amenability to modern molecular tools make it an excellent model system for studying mitochondrial proteins like NADH-ubiquinone oxidoreductase chain 3.

What is the structure and function of NADH-ubiquinone oxidoreductase chain 3 (ND3) in mitochondria?

NADH-ubiquinone oxidoreductase chain 3 (ND3) is a crucial component of mitochondrial complex I (NADH:ubiquinone oxidoreductase, EC 1.6.5.3), which forms an L-shaped structure embedded in the inner mitochondrial membrane . This complex transfers electrons from NADH to ubiquinone coupled with proton translocation to the intermembrane space .

In P. anserina, ND3 consists of 137 amino acids with the following sequence: MSSMTLFILFVSIIALLFLFINLIFAPHNPYQEKYSIFECGFHSFLGQNRTQFGVKFFIF ALVYLLLDLEILLTFPFAVSEYVNNIYGLIILLGFITIITIGFVYELGKSALKIDSRQVI TMTRFNYSSTIEYLGKI . The protein is primarily hydrophobic, suggesting it is embedded within the membrane portion of complex I. As part of complex I, ND3 contributes to the proton-pumping mechanism that generates the electrochemical gradient necessary for ATP synthesis, making it essential for cellular energy metabolism.

How are ND genes distributed and conserved across fungal species?

The mitochondrial genes encoding NADH dehydrogenase subunits (ND genes) show varying distribution patterns across fungal species. Comparative analysis reveals that ND genes in P. anserina share varying degrees of homology with those in other species:

ND GeneConservation between C. parapsilosis and P. anserina (% identity)Conservation between C. parapsilosis and H. sapiens (% identity)
ND152.1%39.5%
ND335.9%29.8%
ND4L51.2%28.6%
ND546.1%38.9%
ND629.7%23.2%

This conservation pattern demonstrates the evolutionary relationships between these organisms while highlighting specific adaptations in different fungal lineages. Hybridization experiments using gene probes have confirmed the presence of ND genes in the mitochondrial DNA of various yeast species including Candida catenulata, Pichia guilliermondii, Clavispora usitaniae, Debaryomyces hansenii, and Hansenula polymorpha . The varying levels of conservation suggest that while the core function of these genes is preserved, species-specific adaptations have occurred throughout evolution.

What are the optimal conditions for expressing recombinant P. anserina ND3 protein?

For optimal expression of recombinant P. anserina ND3 protein, researchers should consider the following methodological approach:

  • Expression System Selection: Due to the hydrophobic nature of ND3 and its mitochondrial localization, eukaryotic expression systems are generally preferred over bacterial systems. Yeast systems (particularly Pichia pastoris) have shown successful expression of mitochondrial proteins.

  • Vector Design: Incorporate a strong inducible promoter (such as AOX1 for P. pastoris) and appropriate secretion signals. Tag selection is critical - fusion tags like His6, GST, or MBP can be employed to facilitate purification and improve solubility, but should be selected based on experimental needs.

  • Culture Conditions: Optimal growth at 25-27°C in appropriate media supplemented with required cofactors . For mitochondrial proteins, addition of heme precursors or iron supplements may improve functional protein production.

  • Purification Strategy: Given that ND3 is a membrane protein, solubilization requires careful selection of detergents (such as n-dodecyl β-D-maltoside or digitonin) that maintain protein structure and function. Purification typically employs affinity chromatography based on the chosen tag, followed by size exclusion chromatography.

  • Quality Control: Verification of proper folding and activity through circular dichroism, thermal shift assays, and functional assays measuring electron transfer capacity.

These parameters must be optimized for each specific experimental system, as minor variations in conditions can significantly impact protein yield and functionality.

How can researchers verify the structural integrity and functional activity of purified recombinant ND3?

Verification of structural integrity and functional activity of purified recombinant ND3 requires a multi-faceted approach:

  • Structural Integrity Assessment:

    • SDS-PAGE and western blotting for size verification and immunological detection

    • Circular dichroism spectroscopy to analyze secondary structure elements

    • Thermal shift assays to evaluate protein stability

    • Limited proteolysis to assess proper folding

    • If feasible, structural characterization through cryo-EM (as part of complex I) or NMR for isolated domains

  • Functional Activity Assays:

    • NADH oxidation assays monitoring the decrease in NADH absorbance at 340 nm

    • Ubiquinone reduction assays to measure electron transfer capacity

    • Membrane potential measurements using fluorescent probes in reconstituted systems

    • Hydrogen peroxide production assays to assess ROS generation

    • Integration into membrane fraction assays to verify proper membrane association

  • Comparative Analysis:

    • Comparison of activity parameters with native complex I from P. anserina mitochondria

    • Analysis of membrane association properties through alkaline extraction and fractionation studies similar to those performed with N. crassa complex I components

A properly functional ND3 should demonstrate stable membrane association, contribute to NADH oxidation and ubiquinone reduction activities, and show expected interactions with other complex I subunits. Alkaline extraction studies with N. crassa have shown that certain complex I subunits remain in the pellet fraction, indicating strong membrane association , which would be expected of a properly folded ND3 protein.

What are the recommended methods for studying ND3's interaction with other subunits of complex I?

To study ND3's interactions with other complex I subunits, researchers should employ these methodological approaches:

  • Cross-linking coupled with mass spectrometry (XL-MS):

    • Use membrane-permeable cross-linkers such as DSS or BS3

    • Identify cross-linked peptides using LC-MS/MS

    • Map interaction surfaces between ND3 and neighboring subunits

  • Blue Native PAGE (BN-PAGE) analysis:

    • Employ gradient gels (3-12% or 4-16%) with mild detergents like digitonin

    • Monitor complex assembly intermediates in wild-type vs. ND3-mutant strains

    • Perform two-dimensional BN/SDS-PAGE to identify subunit composition at different assembly stages

  • Co-immunoprecipitation and pull-down assays:

    • Utilize epitope-tagged ND3 for pull-down experiments

    • Identify interacting partners through proteomic analysis

    • Validate interactions with reciprocal pull-downs

  • Proximity labeling approaches:

    • Express ND3 fused to proximity labeling enzymes (BioID or APEX2)

    • Identify labeled proteins as potential interaction partners

    • Confirm interactions through orthogonal methods

  • Genetic interaction studies:

    • Create single and double mutants as demonstrated with the 13.4-kDa and 13.4L proteins in N. crassa

    • Analyze respiratory phenotypes and complex I assembly states

    • Perform BN-PAGE analysis of mutant strains to assess complex I integrity

Studies in N. crassa have demonstrated how complex I assembly can be monitored through BN-PAGE analysis of different mutant strains, revealing that some subunits (like the 13.4-kDa and 13.4L proteins) are not essential for complex assembly despite their conservation . Similar approaches can be applied to study ND3's role in P. anserina complex I assembly and function.

How does ND3 contribute to mitochondrial dysfunction and aging in P. anserina?

P. anserina serves as an excellent model organism for studying aging due to its well-characterized senescence process. The contribution of ND3 to mitochondrial dysfunction and aging involves several interconnected mechanisms:

  • ROS Production and Oxidative Damage:

    • Complex I is a major site of reactive oxygen species (ROS) production in mitochondria

    • ND3, as part of the membrane arm of complex I, contributes to the formation of the proton-pumping machinery

    • Mutations or dysfunction in ND3 can lead to electron leakage and increased ROS production

    • Accumulated oxidative damage to mitochondrial proteins and DNA accelerates the aging process

  • Energy Metabolism Impairment:

    • Dysfunction in ND3 affects electron transfer efficiency in complex I

    • This leads to decreased ATP production and bioenergetic deficiency

    • Studies in P. anserina have shown that alterations in energy metabolism significantly impact lifespan, as demonstrated by the effects of oleic acid diet on energy metabolism and lifespan extension

  • Mitochondrial Quality Control:

    • Impaired complex I function activates mitochondrial quality control mechanisms including mitophagy

    • In P. anserina, alterations in autophagy pathways influence lifespan, as seen in the Δ PaAtg24 mutant strain

    • The balanced functioning of these pathways is critical for removing damaged mitochondria and maintaining cellular homeostasis

  • Membrane Integrity and Trafficking:

    • ND3 dysfunction can affect mitochondrial membrane composition and integrity

    • Membrane trafficking defects have been associated with aging in P. anserina

    • Proper vacuole formation and membrane trafficking are essential for cellular homeostasis and lifespan regulation

The interconnected nature of these mechanisms highlights why mitochondrial function, particularly that of complex I components like ND3, is central to the aging process in P. anserina and potentially in other organisms.

What are the implications of ND3 mutations for understanding human mitochondrial diseases?

ND3 mutations have significant implications for understanding human mitochondrial diseases due to the conserved nature of mitochondrial function across species. Analysis of P. anserina ND3 provides valuable insights through comparative approaches:

  • Conservation and Functional Parallels:

    • Sequence comparison shows approximately 30% identity between P. anserina and human ND3

    • Despite moderate sequence conservation, structural and functional elements are often preserved

    • This conservation allows for insights from fungal models to be cautiously extrapolated to human mitochondrial disease mechanisms

  • Pathogenic Mechanisms:

    • Studies in P. anserina reveal how ND3 dysfunctions affect:

      • Complex I assembly and stability

      • ROS production and oxidative stress

      • Bioenergetic capacity

      • Mitochondrial membrane integrity

    • These same pathways are implicated in human mitochondrial diseases including Leigh syndrome, MELAS, and certain forms of Leber's hereditary optic neuropathy

  • Compensatory Mechanisms:

    • P. anserina research has identified cellular responses that compensate for mitochondrial dysfunction

    • For example, oleic acid diet can normalize membrane trafficking and autophagy defects in certain P. anserina mutants

    • Understanding these compensatory mechanisms may provide therapeutic targets for human mitochondrial diseases

  • Disease Modeling:

    • Specific ND3 mutations identified in human patients can be recreated in P. anserina

    • The fungal model allows rapid assessment of pathogenicity and compensatory mechanisms

    • Screening for compounds that rescue function in mutant P. anserina strains may identify potential therapeutics for human diseases

While direct translation of findings from fungal models to human disease requires caution, the highly conserved nature of mitochondrial function makes P. anserina ND3 studies valuable for understanding fundamental aspects of mitochondrial diseases and identifying potential therapeutic approaches.

How can recombinant ND3 be used in structural biology studies of mitochondrial complex I?

Recombinant ND3 provides valuable opportunities for advancing structural biology studies of mitochondrial complex I through several methodological approaches:

  • Cryo-EM Structure Determination:

    • Recombinant ND3 can be incorporated into reconstituted complex I for high-resolution cryo-EM studies

    • Site-specific labeling of recombinant ND3 with gold nanoparticles or other electron-dense markers helps locate ND3 within the complex structure

    • Systematic mutagenesis of specific ND3 residues can reveal their roles in complex assembly and function through structural changes

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

    • Recombinant ND3 allows investigation of protein dynamics and conformational changes

    • Comparative HDX-MS between wild-type and mutant ND3 variants can identify regions involved in conformational transitions during catalysis

    • This approach can reveal how ND3 contributes to the coupling mechanism between electron transfer and proton pumping

  • Solid-State NMR Studies:

    • Isotopically labeled recombinant ND3 (15N, 13C) enables solid-state NMR studies of the membrane-embedded protein

    • This approach provides atomic-level insights into protein-lipid interactions and secondary structure elements

    • Dynamics studies can reveal functional movements during the catalytic cycle

  • Computational Modeling:

    • Structural data from recombinant ND3 enables refined computational models of complex I

    • Molecular dynamics simulations can predict conformational changes and functional mechanisms

    • Integration of experimental data with computational approaches generates testable hypotheses about ND3's role in complex I function

  • Site-Directed Spin Labeling and EPR Spectroscopy:

    • Strategic incorporation of spin labels in recombinant ND3 enables EPR studies

    • Distance measurements between spin-labeled sites provide constraints for structural modeling

    • Changes in spin label mobility reveal conformational transitions during complex activation

These approaches collectively provide complementary data for understanding ND3's structural role in complex I, potentially revealing new insights into the coupling mechanism between electron transfer and proton translocation.

What are the major technical challenges in expressing and purifying functional recombinant ND3?

Researchers face several significant technical challenges when expressing and purifying functional recombinant ND3:

  • Membrane Protein Expression Barriers:

    • Hydrophobic nature of ND3 often leads to aggregation or inclusion body formation

    • Toxicity to host cells due to membrane disruption during overexpression

    • Proper membrane insertion is critical for correct folding but difficult to control in heterologous systems

    • Solutions include using specialized expression strains, fusion partners that enhance solubility, and careful regulation of expression levels

  • Maintaining Structural Integrity:

    • ND3 naturally exists within the complex I structure and may not fold properly in isolation

    • Native interactions with other complex I subunits stabilize the protein's conformation

    • Researchers should consider co-expression with interacting partners or expression of larger functional modules

    • Detergent selection is critical - too harsh and the protein denatures, too mild and it aggregates

  • Post-translational Modifications:

    • Proper processing of mitochondrial targeting sequences

    • Potential requirements for specific lipid environments for function

    • Possible redox-sensitive modifications that affect activity

    • Consider using eukaryotic expression systems that more closely mimic the native environment

  • Functional Verification Challenges:

    • Isolated ND3 may not display measurable activity outside of the complex I context

    • Development of specialized assays to verify correct folding and function

    • Requirements for reconstitution into membrane mimetics (nanodiscs, liposomes) for functional studies

  • Stability Issues:

    • Short half-life of isolated membrane proteins in solution

    • Need for specialized stabilizing buffers and storage conditions

    • Consider approaches used for other complex I components, such as the alkaline extraction methods used with N. crassa proteins to assess membrane association

Addressing these challenges requires an integrated approach combining optimized expression systems, careful detergent selection, and development of specialized purification and characterization methods tailored to the unique properties of ND3.

How can CRISPR-Cas9 gene editing be applied to study ND3 function in P. anserina?

CRISPR-Cas9 gene editing technology offers powerful approaches for studying ND3 function in P. anserina through precise genetic modifications:

  • Targeted Mutagenesis Strategies:

    • Creation of point mutations that mimic human disease variants to study pathomechanisms

    • Introduction of conservative mutations to identify functionally critical residues

    • Site-directed mutagenesis of predicted proton channels or ubiquinone binding sites

    • Implementation protocols should include:

      • Optimized sgRNA design for mitochondrial targets

      • Appropriate selection markers for P. anserina transformation

      • Verification of mitochondrial genome editing through PCR and sequencing

  • Domain Swapping and Chimeric Proteins:

    • Replace segments of P. anserina ND3 with corresponding regions from human or other species

    • Create chimeric proteins to identify species-specific functional adaptations

    • Swap domains between different complex I subunits to test functional hypotheses

    • Each construct requires careful design of homology arms and PAM site selection

  • Reporter Systems:

    • Knock-in fluorescent tags to monitor ND3 localization and turnover

    • Create fusion proteins with split reporters to study protein-protein interactions

    • Introduce epitope tags for purification and immunodetection

    • Design considerations should include maintaining protein function after tag insertion

  • Conditional Expression Systems:

    • Generate controllable ND3 expression using inducible promoters

    • Create temperature-sensitive variants to study ND3 function under different conditions

    • Develop systems for rapid protein degradation to study acute effects of ND3 loss

    • Protocol optimization should focus on tight regulation of expression levels

  • Multi-gene Editing Approaches:

    • Create double mutants affecting multiple complex I subunits similar to the approach used with 13.4-kDa and 13.4L proteins in N. crassa

    • Investigate compensatory mechanisms by simultaneously modifying ND3 and potential compensatory factors

    • Perform systematic gene deletion studies to identify synthetic lethal interactions

Implementation of these approaches requires optimization for the P. anserina mitochondrial genome, including development of mitochondria-targeted Cas9 delivery systems and appropriate transformation protocols for this filamentous fungus.

What new insights might comparative analysis of ND3 across fungal species provide for respiratory chain evolution?

Comparative analysis of ND3 across fungal species offers significant potential for uncovering evolutionary insights about respiratory chain development and adaptation:

  • Evolutionary Rate Analysis:

    • ND3 shows variable conservation levels across species (approximately 36% identity between C. parapsilosis and P. anserina)

    • Identification of rapidly evolving vs. highly conserved regions suggests functional constraints

    • Correlation between evolutionary rates and environmental adaptation provides insights into selective pressures

    • Systematic comparison of synonymous vs. non-synonymous substitution rates can reveal selection signatures

  • Structure-Function Relationship Mapping:

    • Comparison of ND3 sequences across species with known phenotypic differences in respiratory function

    • Identification of co-evolving residues suggests functional interactions

    • Mapping of conserved motifs to structural elements reveals critical functional domains

    • Correlation of sequence variations with differences in energy metabolism efficiency

  • Respiratory Chain Complex I Diversity:

    • Some fungal species (like Saccharomyces cerevisiae) lack the conventional complex I and utilize alternative NADH dehydrogenases

    • Comparative analysis can reveal evolutionary transitions and adaptations in energy metabolism

    • Investigation of ND3 retention or loss across lineages provides insights into respiratory chain evolution

    • Analysis of compensatory mechanisms in species with altered complex I composition

  • Environmental Adaptation Signatures:

    • Correlation between ND3 sequence features and ecological niches of different fungal species

    • Identification of adaptations that optimize function under different temperature, oxygen, or nutrient conditions

    • Investigation of how these adaptations influence longevity and senescence across species

    • Potential insights into how environmental factors shape mitochondrial evolution

  • Horizontal Gene Transfer Assessment:

    • Investigation of potential horizontal gene transfer events involving ND3

    • The finding that gene cluster orthologs between Aspergillus nidulans and P. anserina have 63% identical primary amino acid sequence (despite these species being from distinct classes) suggests potential shared genetic heritage

    • Analysis of phylogenetic incongruencies that might indicate horizontal gene transfer events

This comparative approach has the potential to reveal how complex I has evolved across fungal lineages, providing insights into both fundamental aspects of respiratory chain function and the adaptive mechanisms that allow organisms to optimize energy metabolism for their specific ecological niches.

How can isotopic labeling of recombinant ND3 enhance structural and functional studies?

Isotopic labeling of recombinant ND3 provides powerful tools for advanced structural and functional studies through multiple specialized applications:

  • NMR Spectroscopy Applications:

    • Uniform 15N/13C labeling enables detailed structural analysis of ND3 through solution or solid-state NMR

    • Selective amino acid labeling strategies can focus on specific regions of interest

    • TROSY-based NMR methods can be applied to the labeled protein in detergent micelles or nanodiscs

    • 2H labeling (deuteration) reduces relaxation effects, improving spectral quality for this membrane protein

    • Methodological considerations include:

      • Optimizing expression in minimal media with labeled precursors

      • Maintaining protein folding under restrictive growth conditions

      • Developing appropriate solubilization strategies that maintain native structure

  • HDX-MS (Hydrogen-Deuterium Exchange Mass Spectrometry):

    • Reveals solvent accessibility and conformational dynamics

    • Can identify regions involved in protein-protein interactions

    • Monitors structural changes associated with complex assembly

    • Implementation requires:

      • Optimization of deuterium labeling times for membrane proteins

      • Development of appropriate quenching and digestion protocols

      • Careful control of back-exchange during analysis

  • IR Spectroscopy Applications:

    • 13C and 18O labeling enables infrared spectroscopic studies of secondary structure

    • Site-specific isotope labeling can monitor local conformational changes

    • Techniques such as ATR-FTIR can be applied to membrane-reconstituted ND3

    • Protocol development should focus on:

      • Preparing oriented samples for polarized measurements

      • Maintaining hydration during measurements

      • Background subtraction strategies for membrane systems

  • Crosslinking Mass Spectrometry:

    • Isotopically labeled crosslinkers create characteristic mass shifts that improve identification

    • Differentially labeled samples can be mixed for comparative studies

    • Implementation considerations include:

      • Selection of appropriate crosslinker chemistry and spacer length

      • Optimization of reaction conditions for membrane proteins

      • Development of specialized data analysis workflows

  • Neutron Scattering Applications:

    • Deuteration creates contrast for neutron scattering studies

    • Can probe protein-lipid interactions in reconstituted systems

    • Provides unique structural information complementary to X-ray methods

    • Requires:

      • High-level deuteration (>90%)

      • Specialized expression systems optimized for deuterated media

      • Access to neutron scattering facilities

These advanced labeling approaches provide complementary data that can significantly enhance our understanding of ND3 structure, dynamics, and interactions within complex I.

What are the recommended approaches for studying the role of ND3 in mitochondrial ROS production?

Investigating ND3's role in mitochondrial reactive oxygen species (ROS) production requires specialized methodological approaches:

  • Site-Directed Mutagenesis Combined with ROS Detection:

    • Target conserved residues near the ubiquinone binding site or proton channels

    • Create point mutations that may alter electron transfer efficiency

    • Measure ROS production using:

      • Fluorescent probes (DCF-DA, MitoSOX, Amplex Red)

      • Electron paramagnetic resonance (EPR) with spin traps

      • Genetically encoded redox sensors (roGFP, HyPer)

    • Protocol optimization should include:

      • Careful calibration with positive controls

      • Subcellular fractionation to isolate mitochondria

      • Time-resolved measurements to capture ROS dynamics

  • Reconstitution Studies with Purified Components:

    • Incorporate wild-type or mutant recombinant ND3 into liposomes or nanodiscs

    • Reconstitute with other complex I components

    • Measure electron transfer rates and ROS production simultaneously

    • Implementation considerations:

      • Protein:lipid ratio optimization

      • Selection of appropriate lipid composition

      • Development of coupled assay systems

  • In vivo Approaches in P. anserina:

    • Generate ND3 variant strains through CRISPR-Cas9 or traditional mutagenesis

    • Monitor growth, lifespan, and senescence phenotypes

    • Correlate phenotypes with measurements of:

      • Mitochondrial membrane potential

      • Oxygen consumption rates

      • ATP production

      • ROS levels using in vivo probes

    • Protocol development should focus on:

      • Non-invasive measurement techniques

      • Time-course studies throughout lifespan

      • Integration of multiple parameters

  • Redox Proteomics Approaches:

    • Identify oxidatively modified proteins in wild-type vs. ND3 mutant strains

    • Map the pattern of oxidative damage within the mitochondrial proteome

    • Quantify site-specific oxidative modifications

    • Methodological considerations include:

      • Preservation of redox state during sample preparation

      • Enrichment strategies for oxidized proteins

      • Mass spectrometry approaches for specific modifications

  • Interaction with Antioxidant Systems:

    • Investigate how ND3 variants affect the expression and activity of antioxidant enzymes

    • Study potential direct interactions between complex I and antioxidant systems

    • Examine compensatory responses to increased ROS

    • Implementation requires:

      • Activity assays for major antioxidant enzymes

      • Transcriptional and translational regulation analysis

      • Genetic interaction studies with antioxidant system components

These approaches provide complementary data on how ND3 contributes to ROS production, offering insights into both the molecular mechanisms of ROS generation and the cellular responses to oxidative stress in P. anserina.

How can researchers investigate the interaction between ND3 function and lipid metabolism in P. anserina?

The interaction between ND3 function and lipid metabolism represents an emerging research area with important implications for understanding mitochondrial function and aging in P. anserina. Recommended methodological approaches include:

  • Lipidomic Analysis Paired with ND3 Functional Studies:

    • Quantify changes in mitochondrial lipid composition in ND3 mutant strains

    • Compare lipid profiles between young and aged cultures

    • Analyze changes induced by oleic acid supplementation, which extends P. anserina lifespan

    • Implementation considerations:

      • LC-MS/MS-based lipidomics for comprehensive profiling

      • Targeted analysis of cardiolipin and other mitochondria-specific lipids

      • Correlation of lipid changes with complex I activity measurements

  • Reconstitution of ND3 in Defined Lipid Environments:

    • Incorporate recombinant ND3 into liposomes with controlled lipid composition

    • Systematically vary lipid types to identify those critical for function

    • Measure electron transfer rates and ROS production

    • Protocol optimization should include:

      • Testing physiologically relevant lipid mixtures

      • Comparing fungal vs. mammalian lipid compositions

      • Assessing protein orientation and membrane insertion

  • Genetic Interaction Studies:

    • Create double mutants affecting both ND3 and lipid metabolism enzymes

    • Analyze synthetic phenotypes and compensatory mechanisms

    • Focus on genes involved in:

      • Fatty acid synthesis and oxidation

      • Phospholipid metabolism

      • Cardiolipin synthesis and remodeling

    • Development considerations include:

      • Selection of appropriate lipid metabolism gene targets

      • Phenotypic assays sensitive to both energetic and lipid alterations

      • Comprehensive mitochondrial function assessment

  • Metabolic Flux Analysis:

    • Trace the metabolic fate of isotopically labeled fatty acids in ND3 variant strains

    • Measure rates of β-oxidation and lipid synthesis

    • Compare with effects of oleic acid supplementation

    • Implementation requires:

      • GC-MS or LC-MS/MS for metabolite analysis

      • Mathematical modeling of metabolic networks

      • Time-course studies to capture dynamic changes

  • Membrane Trafficking and Autophagy Assessment:

    • Investigate how ND3 function affects membrane trafficking pathways

    • Monitor autophagy and mitophagy rates

    • Study vacuole formation and function

    • Based on findings that oleic acid diet abolishes vacuole formation defects in certain P. anserina mutants

    • Methodological approaches include:

      • Fluorescent protein tagging of key components (e.g., PaSNC1::mCherry)

      • Live-cell imaging of membrane dynamics

      • Quantitative assessment of autophagic flux

This multi-faceted approach can reveal how ND3 function influences and is influenced by lipid metabolism, potentially uncovering new therapeutic targets for mitochondrial dysfunction and age-related diseases.

What are the most promising future research directions for P. anserina ND3 studies?

Research on P. anserina ND3 is poised for significant advancements in several promising directions:

  • Integration of Structural and Functional Studies:

    • Combining high-resolution structural data with functional assays to map the relationship between ND3 structure and function

    • Applying cryo-EM to visualize conformational changes during the catalytic cycle

    • Developing structure-based hypotheses for testing through site-directed mutagenesis

    • This integrated approach will provide mechanistic insights into how ND3 contributes to complex I function

  • Systems Biology Approaches:

    • Multi-omics integration (transcriptomics, proteomics, metabolomics, lipidomics) to understand the broader impacts of ND3 dysfunction

    • Network analysis to identify compensatory pathways activated in response to complex I defects

    • Mathematical modeling of mitochondrial energy metabolism incorporating experimental data

    • These approaches will reveal how ND3 dysfunction propagates through cellular systems

  • Comparative Studies Across Species:

    • Expanding comparative analyses to include diverse fungal species and other eukaryotes

    • Identifying evolutionary adaptations in ND3 that correlate with species lifespan or ecological niche

    • Testing conserved features through heterologous expression experiments

    • Such studies will provide evolutionary context for ND3 function and potentially identify novel therapeutic targets

  • Therapeutic Intervention Development:

    • Screening for compounds that can rescue ND3 dysfunction

    • Testing how dietary interventions (like oleic acid supplementation) affect complex I function

    • Developing gene therapy approaches for mitochondrial DNA editing

    • These translational efforts may lead to therapies for mitochondrial diseases

  • Novel Technology Application:

    • Implementing mitochondria-targeted CRISPR systems for precise genetic manipulation

    • Developing advanced imaging techniques for studying ND3 dynamics in living cells

    • Creating synthetic biology approaches to engineer optimized ND3 variants

    • Technological innovations will enable previously impossible experiments

These research directions collectively promise to advance our understanding of ND3's role in mitochondrial function, with potential applications extending from fundamental biology to human disease treatment.

How might research on fungal ND3 translate to therapeutic approaches for human mitochondrial diseases?

Research on fungal ND3 has significant potential to inform therapeutic approaches for human mitochondrial diseases through several translational pathways:

  • Drug Discovery Platforms:

    • P. anserina serves as a rapid screening system for compounds that rescue ND3 dysfunction

    • Fungal models allow testing of drug effects on:

      • Complex I assembly and stability

      • ROS production

      • Mitochondrial membrane potential

      • ATP synthesis

    • Hits from fungal screens can be prioritized for testing in mammalian models

    • Implementation strategies should focus on:

      • Development of high-throughput screening protocols

      • Selection of disease-relevant readouts

      • Validation in multiple fungal species to minimize false positives

  • Identification of Compensatory Pathways:

    • Studies in P. anserina reveal natural mechanisms that compensate for complex I dysfunction

    • Oleic acid's beneficial effects on membrane trafficking and autophagy provide one example

    • These pathways represent potential therapeutic targets

    • Translational approaches include:

      • Testing identified pathways in patient-derived cells

      • Developing compounds that activate compensatory mechanisms

      • Nutritional interventions based on fungal findings

  • Structure-Function Insights for Rational Drug Design:

    • Detailed structural understanding of fungal ND3 informs structure-based drug design

    • Identification of functional hotspots that could be targeted by small molecules

    • Development of protein-protein interaction inhibitors or enhancers

    • Implementation considerations include:

      • Focusing on highly conserved regions between fungal and human proteins

      • Developing assays to measure specific functional aspects

      • Creating computational models to predict drug interactions

  • Gene Therapy Development:

    • Fungal models provide testbeds for mitochondrial gene delivery approaches

    • Validation of gene editing technologies targeting mitochondrial DNA

    • Assessment of heteroplasmy management strategies

    • Translational pathway requires:

      • Optimization of mitochondrial targeting sequences

      • Development of delivery vectors effective for mitochondria

      • Validation of editing efficiency and specificity

  • Biomarker Identification:

    • Fungal studies reveal metabolic signatures of ND3 dysfunction

    • These signatures can be investigated as potential biomarkers in human patients

    • Early disease detection or treatment monitoring tools

    • Implementation requires:

      • Validation in patient samples

      • Development of sensitive detection methods

      • Correlation with disease progression

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.